Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000922423-02-000192
Filing Date
2002-02-14
Accepted
2002-02-14 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G kl02011_sc13g.txt SC 13G 9030
  Complete submission text file 0000922423-02-000192.txt   11131
Mailing Address 1775 BROADWAY 26TH FLOOR NEW YORK NY 10019
Business Address 1775 BROADWAY 26TH FLOOR NEW YORK NY 10019 2127652500
GILDER GAGNON HOWE & CO LLC (Filed by) CIK: 0000902464 (see all company filings)

EIN.: 133174112 | State of Incorp.: NY | Fiscal Year End: 1231

Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 100 CORPORATE NORTH STE 215 BANNOCKBURN IL 60015 8472958678
NEOPHARM INC (Subject) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-49690 | Film No.: 02546092
SIC: 2836 Biological Products, (No Diagnostic Substances)